Mirae Asset Venture Investment

Type

Venture Capital

Status

Active

Location

Seoul, South Korea

Total investments

251

Average round size

35M

Portfolio companies

181

Rounds per year

10.04

Lead investments

16

Follow on index

0.28

Exits

9

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyE-CommerceSoftwareInformation TechnologyArtificial IntelligenceMachine LearningHealth CareAppsPharmaceuticalTherapeutics

Summary

Mirae Asset Venture Investment appeared to be the VC, which was created in 1999. The company was established in Asia in South Korea. The leading representative office of defined VC is situated in the Seongnam.

The typical startup value when the investment from Mirae Asset Venture Investment is 50-100 millions dollars. Opposing the other organizations, this Mirae Asset Venture Investment works on 21 percentage points less the average amount of lead investments. The top activity for fund was in 2019. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top amount of exits for fund were in 2014. Speaking about the real fund results, this VC is 6 percentage points more often commits exit comparing to other organizations. The fund is generally included in 2-6 deals every year.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Mirae Asset Venture Investment, startups are often financed by Softbank Ventures Asia, Kakao Ventures, Smilegate Investment. The meaningful sponsors for the fund in investment in the same round are Korea Investment Partners, Softbank Ventures Asia, Smilegate Investment. In the next rounds fund is usually obtained by Softbank Ventures Asia, Legend Capital, InterVest Co..

Besides them, we counted 4 critical employees of this fund in our database.

Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Evofem Biosciences, Arcellx, Ium. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - South Korea.

Show more

Investor highlights

Industry generalist
Yes
Industry focus
GeneralistManufacturingBiotech/Life SciencesTelecommunications
Stage focus
Seed
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
251
Lead investments
16
Exits
9
Rounds per year
10.04
Follow on index
0.28
Investments by industry
  • Software (44)
  • Biotechnology (43)
  • E-Commerce (35)
  • Information Technology (34)
  • Health Care (29)
  • Show 213 more
Investments by region
  • South Korea (162)
  • China (9)
  • India (12)
  • United States (46)
  • Singapore (5)
  • Show 6 more
Peak activity year
2021
Number of Unicorns
5
Number of Decacorns
7
Number of Minotaurs
4

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Avg. valuation at time of investment
883M
Group Appearance index
0.94
Avg. company exit year
6
Strategy success index
0.80

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Chengdu Pukang Biotechnology Co. 06 Jun 2024 Early Stage Venture Sichuan, Chengdu, China
Perigee Aerospace 01 Nov 2019 Aerospace, Service Industry Early Stage Venture 12M Taejon-jikhalsi, Daejeon, South Korea

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.